PODCAST
Rethinking the Use of Anticholinergics in Older Adults Diagnosed with Tardive Dyskinesia
Tune in as Jennifer Mondillo, a gerontology nurse practitioner, and Rob Leffler, a board-certified geriatric pharmacist, explain the inappropriate use of anticholinergic medications to treat older adults with tardive dyskinesia (TD), a drug-induced movement disorder. These experts emphasize the importance of reducing or eliminating the anticholinergic burden in patients with TD and discuss practical approaches to evaluating anticholinergic use in LTC residents with drug-induced movement disorders, de-prescribing, and treating TD with VMAT2 inhibitors.
This podcast has been sponsored and co-developed by Neurocrine Biosciences, Inc. This podcast is for educational purposes only and is not intended to promote any specific product. The speakers are presenting on behalf of and are paid consultants for Neurocrine Biosciences. The information provided herein is based upon the healthcare provider’s clinical judgment and personal experience.
PODCAST
Treatment Approaches to Tardive Dyskinesia
Listen in as Dr. Dawn Vanderhoef, a Senior Medical Director of Medical Affairs at Neurocrine, and Dr. Kaylee Mehlman, a clinical geriatric pharmacist, share their insights on therapeutic approaches to tardive dyskinesia, exploring its pathophysiology, its impact on the lives of patients, and management strategies for clinicians.
This podcast is sponsored and co-developed by Neurocrine Biosciences, Inc. This podcast is for educational purposes only and is not intended to promote any specific product. Both speakers are Neurocrine employees, and Dr. Kaylee Mehlman served as a paid consultant at the time of recording in February 2024. The content reflects Dr. Mehlman’s clinical judgment and personal experience.
